MarketInOut Stock Screener Log In | Sign Up
 

AbbVie Inc

IEX • Healthcare • Drug Manufacturers - General • Quote as of 10/16/2026
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeIEX
Market Capitalization500,942 mln
Float1,765 mln
Earnings Date10/30/2026

EPS

3.54
Stretched

P / E

80.62
Speculative

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.86
Likely reliable

1-Year Forecast

282.61
Fairly priced

Relative Strength

94 / 100
Top performer

Business Description

AbbVie is a global pharmaceutical company founded in 2012 and based in North Chicago, Illinois, that develops and sells treatments across a wide range of medical conditions. Its portfolio includes medicines for blood cancers, autoimmune and inflammatory diseases, neurological disorders, migraines, and eye conditions, as well as therapies for hepatitis C and digestive health. The company also has a strong presence in aesthetics, offering products such as Botox and the Juvederm collection for cosmetic and skin-related treatments.

Key Fundamentals

EPS3.54
P/E80.62
ROE-136
RPS36.39
ROIC14.21
ROA4.66
Interest Cover7.13
EBITDA, mln19,694
EV / EBITDA26.94
EV / EBIT45.02
Revenue, mln64,386
EV / Revenue8.24

Quote Details

Last 285.42
Change 2.02 (0.71%)
Open 283.61
Volume 3,815,159
Turnover 1,088,922,752
Average Volume 3,043,163

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio0.81
Price / Cash Flow25.74
Price / Free Cash Flow25.64
Price / Sales7.23
PEG Ratio0.56

Financial Strength

Altman Z-Score2.49
Piotroski F-Score 8 / 9
Beneish M-Score-2.86
Price to Intrinsic Value2.58
1-Year Target Price282.61
Shiller PE Ratio54.63
Short Ratio3.93
Short % of Float1.02

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.86% 89 / 100   
1 Month 8.75% 94 / 100   
2 Months 16.6% 91 / 100   
6 Months 38.78% 94 / 100   
1 Year 29.87% 77 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us